Join us as we examine the latest findings from the 2024 Avoca Industry Report, which gathered perspectives from sponsors, CROs, and sites on awareness, anticipated impact, and preparedness for impending ICH E6 (R3) regulatory guidance updates. This webinar will offer valuable insights into which stakeholders might encounter the most significant challenges, the potential effects on clinical trial conduct, and the measures organizations are implementing to prepare.